Veracyte Inc
NASDAQ:VCYT

Watchlist Manager
Veracyte Inc Logo
Veracyte Inc
NASDAQ:VCYT
Watchlist
Price: 42.17 USD 2.6% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
Veracyte Inc?
Write Note

EV/FCFF
Enterprise Value to FCFF

53
Current
38
Median
3.6
Industry
Higher than median
Higher than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
53
=
Enterprise Value
3B USD
/
FCFF
56.5m USD
All Countries
Close
Market Cap EV/FCFF
US
Veracyte Inc
NASDAQ:VCYT
3.3B USD 53
FR
Pharnext SCA
OTC:PNEXF
6T USD -238 095.9
US
Abbvie Inc
NYSE:ABBV
314.7B USD 23.4
US
Amgen Inc
NASDAQ:AMGN
147.4B USD 31.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD -82.6
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 10.9
US
Epizyme Inc
F:EPE
94.1B EUR -471.1
AU
CSL Ltd
ASX:CSL
135.4B AUD 64.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 22.8
US
Seagen Inc
F:SGT
39.3B EUR -56.8
NL
argenx SE
XBRU:ARGX
34.3B EUR -100.8

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More